Majority of patients cancer-free after treatment developed at Rice

[Ralph1966]

houstonchronicle.com/news/s...

But they included only low and intermediate risk PCa. Is this excluding Gleson 8-10?

[tango65]

Very interesting. Thanks for posting. This is a link to the full article:

sci-hub.tw/https://www.pnas...

Best of luck.

[NPfisherman]

Another poster contacted the team that developed this treatment... at this time, they are only looking at localized disease and not treating mets...They told him that metastatic disease requires systemic therapy, so no treatment for us.... Saddening, as this could be used for people with visceral mets and areas that can not be treated easily... They said they would be looking at additional uses in the future...here's hoping....

Don Pescado

[sjc2 in reply to NPfisherman]

So is this treatment only for people who haven't already had radical surgery and recurrence, even if the only thing that shows up is one small pelvic lymph node and they are still hormone sensitive? I tried to read the full article, but it's way over my head I'm afraid!

[NPfisherman in reply to sjc2]

It is for people with local disease only--prostate specific.... not for someone with mets--even one met...let's hope they see the value of being something more than just local disease treatment--for people with liver or lung mets, this could be a good thing...

Don Pescado

[sjc2 in reply to NPfisherman]

Thanks! To bad, wish it would have been an option!

[Magnus1964]

Great information, thanks.

[larry_dammit]

Got to start somewhere

[Hidden]

A lot of techniques are being tried and tested out of the Texas Medical Center complexing involving academia and research. I first heard about this technique in 2004. Nice to hear about the results. It will prove to be another method of primary treatment.

In my case, I had mets and they were attacked by aggressive systemic treatment while the “tumor burden was minimal and body strong” in a six month clinical trial of chemotherapy with hormone therapy. Note, my chemotherapy was very different than the standard application used then and today. I was most fortunate to be one of nine with complete response in the trial. The common denominator: very early in metastases before cancer had a chance to ravished the body.

Cmdrdata was treated with the same protocol outside of the trial. He might comment.

From my personal perspective, and most think antidotal, until the medical community return to annual PSA testing at 40 and monthly PSA testing during and after primary treatment, metastatic lesions will take hold. Depending on the delay and the use multiple infusion and oral therapies, the battle to kill the little bastards will be handicapped. PSA testing and nuclear bone and soft tissue CT scans are the still best way to monitor what is going on with your body.

I have no scientific proof other than a perceived increase in metastasis upon initial diagnosis the based on membership in two distinct groups - PCa and the other Advanced PCa,

Oh yes, there have been great advances in technology during the past 15 years, however, often interpretation based on standards of care, are often skewed. To me, and no one could ever change my mind, there is a large difference between community oncologists and academia oncologist. The world needs more doctors who shun the riches of private practice and exist on a teachers salary and corresponding research grants. But, who am I other than a very biased survivor........

Gourd Dancer